Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -4.00 (-0.76%)
Bid:
521.00
Ask:
522.00
Spread: 1.00 (0.192%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Contract

20 Oct 2025 07:00

RNS Number : 8983D
Galliford Try Holdings PLC
20 October 2025
 

GALLIFORD TRY APPOINTED TO MAJOR NEW £3 BILLION AFFORDABLE HOMES FRAMEWORK

Galliford Try's Building business has been appointed to a £3 billion affordable homes framework by major Registered Provider (RP), The Hyde Group.

The business has been confirmed on all seven lots of the new Main Contractor framework across the East, South and London regions the 120,000-home RP operates in. The framework runs for five years and is targeting building 1,500 homes per year during that period.

Bill Hocking, Chief Executive of Galliford Try, commented: "Delivering low to mid-rise apartment blocks for the affordable homes market is a key part of our Sustainable Growth Strategy to 2030, and we are delighted to have achieved a place on this major framework with a housing association that has a significant track record in development. We look forward to working with Hyde to bring forward the much-needed high-quality homes that their customers deserve."

 

Galliford Try

 

Bill Hocking, Chief Executive 01895 855001

Kris Hampson, Chief Financial Officer

Kevin Corbett, General Counsel & Company Secretary

 

Notes to editors 

 

Galliford Try Holdings plc is a leading UK construction group listed on the London Stock Exchange, and a member of the FTSE 250. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure projects with clients in the public, private and regulated sectors across the UK.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFZMMGDNVGKZM
Date   Source Headline
17th Nov 20237:00 amRNSCompletion of Share Buyback Programme
16th Nov 20234:30 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20233:00 pmRNSResult of AGM
10th Nov 20237:00 amRNSAGM Statement
9th Nov 20237:00 amRNSAcquisition
8th Nov 20237:00 amRNSDirectorate Change
7th Nov 20237:00 amRNSContract
2nd Nov 20235:51 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSTransaction in Own Shares
30th Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20239:14 amRNSTransaction in Own Shares
23rd Oct 202311:05 amRNSDirectorate Change
18th Oct 20237:00 amRNSTransaction in Own Shares
13th Oct 20237:00 amRNSTransaction in Own Shares
6th Oct 20233:30 pmRNSAnnual Financial Report
3rd Oct 202310:15 amRNSEmployee Share Trust Trading Plan
2nd Oct 202310:30 amRNSTotal Voting Rights
28th Sep 20233:05 pmRNSDirector/PDMR Shareholding
28th Sep 20233:00 pmRNSDirector/PDMR Shareholding
26th Sep 20234:30 pmRNSDirector/PDMR Shareholding
25th Sep 20234:15 pmRNSDirector/PDMR Shareholding
22nd Sep 20233:00 pmRNSHolding(s) in Company
21st Sep 20232:30 pmRNSBlock listing Interim Review
20th Sep 20237:00 amRNSFinal Results
12th Sep 20237:00 amRNSTransaction in Own Shares
8th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20237:00 amRNSTransaction in Own Shares
6th Sep 20237:00 amRNSTransaction in Own Shares
4th Sep 20237:00 amRNSTransaction in Own Shares
1st Sep 202310:30 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSTransaction in Own Shares
31st Aug 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 202311:00 amRNSAppointment of Joint Broker
22nd Aug 20237:00 amRNSTransaction in Own Shares
21st Aug 20232:00 pmRNSHolding(s) in Company
21st Aug 20237:00 amRNSTransaction in Own Shares
18th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20237:00 amRNSContract
7th Aug 20235:16 pmRNSHolding(s) in Company
7th Aug 20232:00 pmRNSHolding(s) in Company
7th Aug 20237:00 amRNSTransaction in Own Shares
3rd Aug 20237:00 amRNSTransaction in Own Shares
1st Aug 202310:00 amRNSTotal Voting Rights
14th Jul 20237:00 amRNSContract
11th Jul 20237:10 amRNSTransaction in Own Shares
11th Jul 20237:00 amRNSTrading Statement
7th Jul 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.